MLAB

Mesa Laboratories Inc

131.22

USD

-0.65

-0.49%

Sep 22, 09:42 UTC -4

Open

Mesa Laboratories Inc Profile

About

MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy.

Info & Links

CEO

Siddhartha Kadia

Headquarters

12100 W 6TH AVE
LAKEWOOD, CO 80228, UNITED STATES

Auditor

Baker TillyLLP

Share holders

Employees

717

Mesa Laboratories Inc Statistics

Valuation Measures

Market Capitalization²

734.29M

Enterprise Value

846.46M

Enterprise Value/EBITDA(ttm)

18.63

Price to Earnings Ratio(ttm)

17.05

Price to Sales(ttm)

2.84

Price to Book(mrq)

3.75

Price to Cash(ytd)

10.75

Profitability

Gross Margin(ttm)

64.19%

Operating Margin(ttm)

16.83%

Profit Margin(ttm)

1.97%

Return on Equity(ttm)

22.72%

Return on Invested Capital(ttm)

1.38%

Return on Assets(ttm)

9.82%

Income Statement

Revenue(ttm)

249.72M

Revenue Per Share(ttm)

44.63

Gross Profit(ttm)

160.34M

EBITDA(ttm)³

45.44M

Net Income Available to Common(ttm)

4.80M

Diluted EPS(ttm)

0.84

Share Statistics

Beta (5Y Monthly)

0.97

52-Week Change

79.41%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

5.60M

Dividend Yield

0.51%

Float⁴

5.44M

% Held by Insiders

2.80%

% Held by Institutions

90.60%

Balance Sheet

Total Cash(mrq)

30.70M

Total Cash Per Share(mrq)

5.49

Total Debt(mrq)

142.87M

Total Debt/Equity(mrq)

75.69%

Current Ratio(mrq)

1.79%

Quick Ratio(mrq)

1.32%

Book Value Per Share(mrq)

33.73

Cash Flow

Operating Cash Flow Per Share(ytd)

2.56

Free Cash Flow(ytd)

14.18M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.